Nebula Research & Development LLC Penumbra Inc Call Options Transaction History
Nebula Research & Development LLC
- $618 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PEN
# of Institutions
378Shares Held
29.6MCall Options Held
285KPut Options Held
168K-
Black Rock Inc. New York, NY4.26MShares$1 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.68MShares$868 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.03MShares$714 Million0.07% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.55MShares$365 Million1.9% of portfolio
-
State Street Corp Boston, MA1.23MShares$291 Million0.01% of portfolio
About Penumbra Inc
- Ticker PEN
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,888,400
- Market Cap $8.94B
- Description
- Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...